VELCADE 3.5 MG VIAL

bortezomib
$1508.2100per EA
High Outlier

Strength

3.5 mg/1

NDC

63020004901

Classification

Brand

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

7/1/2016

Active Ingredients

BORTEZOMIB

Approval Type

New Drug (NDA)

FDA Application

NDA021602

On Market Since

5/13/2003

Pharmacological Classes

Proteasome Inhibitor
Proteasome Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+1.1%

Related Drugs

Same classification

No related drugs found.